Close Menu

NEW YORK (GenomeWeb) – Mammoth Biosciences, a biotech startup cofounded by CRISPR researcher Jennifer Doudna, made a splash when it came out of stealth mode late last month with backing from several venture capital firms, a license for CRISPR technology from the University of California, and a plan for a CRISPR-based disease detection platform that the company said would have both at-home and hospital-use versions.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.